Filing Details
- Accession Number:
- 0001209191-10-030744
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-27 13:00:00
- Reporting Period:
- 2010-05-25
- Filing Date:
- 2010-05-27
- Accepted Time:
- 2010-05-27 14:07:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1472595 | Accretive Health Inc. | AH | Services-Management Services (8741) | 020698101 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1262312 | Accretive Investors Sbic Lp | 51 Madison Avenue 31St Floor New York NY 10010 | No | No | Yes | No | |
1492319 | Accretive Associates Sbic, Llc | 51 Madison Avenue 31St Floor New York NY 10010 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-05-25 | 20,908,996 | $0.00 | 20,908,996 | No | 4 | C | Indirect | See Footnote |
Common Stock | Disposition | 2010-05-25 | 865,520 | $11.28 | 20,043,476 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2010-05-25 | 129,828 | $11.28 | 19,913,648 | No | 4 | S | Indirect | See Footnote |
Common Stock | Acquisiton | 2010-05-25 | 603,218 | $12.00 | 20,516,866 | No | 4 | J | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | J | Indirect | See Footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Convertible Preferred Stock | Disposition | 2010-05-25 | 15,927 | $0.00 | 19,136,400 | $0.00 |
Common Stock | Series D Convertible Preferred Stock | Disposition | 2010-05-25 | 452,193 | $0.00 | 1,772,596 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Each share of Series A Convertible Preferred Stock represented herein converted into 1,201.5069 shares of common stock, par value $0.01 per share, of the Issuer (the "Common Stock"), and had no expiration date. Each share of Series D Convertible Preferred Stock represented herein converted into 3.92 shares of Common Stock and had no expiration date.
- Accretive Investors SBIC, L.P. directly beneficially owns the reported securities. Accretive Associates SBIC, LLC is the general partner of Accretive Investors SBIC, L.P. J. Michael Cline is the managing member of Accretive Associates SBIC, LLC and serves on the board of directors of Accretive Health, Inc. Each of Accretive Investors SBIC, L.P. and Accretive Associates SBIC, LLC disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest therein, if any.
- Reflects shares of Common Stock received in satisfaction of a liquidation preference required to be made to Accretive Investors SBIC, L.P. in connection with the close of the Issuer's initial public offering.